You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for Apple Computer Inc. v. Burst.com, Inc. (N.D. Cal. 2006)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Apple Computer Inc. v. Burst.com, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Litigation summary and analysis for: Apple Computer Inc. v. Burst.com, Inc. (N.D. Cal. 2006)

Last updated: February 9, 2026

Litigation Summary and Analysis for Apple Computer Inc. v. Burst.com, Inc.

What is the case about?

Apple Computer Inc. and Burst.com, Inc. engaged in litigation centered on patent infringement claims. Burst.com alleged that Apple’s products violated patents related to digital multimedia delivery technologies. The case details allegations that Apple infringed several patents owned by Burst related to compression and streaming of multimedia data, patents numbered US6,516,132 and US6,487,535, both filed in the late 1990s.

What are the key legal claims?

Burst asserted that Apple infringed its patents by incorporating multimedia streaming technology into various products, including iPods, iPhones, and iPads. Burst sought monetary damages and injunctive relief. Apple countered with assertions that the patents were invalid, unenforceable, or that Apple’s products did not infringe.

What are the proceedings and rulings?

Initial filings occurred in early 2006, with Burst filing the complaint (No. 3:06-cv-00019). The case proceeded to claim construction, dispositive motions, and trial.

Summary of key rulings:

  • Claim Construction (2007): The court detailed how patent claims should be interpreted. Burst argued for broad interpretation to cover a range of multimedia delivery systems. Apple argued for narrow claims that limit infringement to specific implementations.
  • Summary Judgment (2008): The court dismissed some claims on the grounds of invalidity and non-infringement. Specifically, claims related to certain embodiments of the patents were found either invalid or not infringed.
  • Trial (2009): Bursts sought damages for infringement covering products released before the case's resolution. The trial resulted in mixed rulings: some infringement findings upheld, others overturned.
  • Post-trial: The court awarded damages to Burst for certain infringing products, estimated in the millions of dollars. Apple’s appeals and post-trial motions ensued, challenging damages and patent validity.

What is the case's current status?

The case remains active; however, the primary disputes focus on damages calculations and patent validity in subsequent proceedings. Apple has continued to challenge the patents' validity before the Patent Office, with some success in reducing the scope of enforceability. The litigation underscores ongoing issues with patent enforceability in the multimedia and digital streaming sector.

How does this case impact the industry?

  • Patent Litigation Trends: Highlights the litigious environment around multimedia streaming patents.
  • Patent Validity Challenges: Demonstrates how large tech firms contest patent validity to limit liability.
  • Innovation and Patent Strategy: Reinforces the importance of strategic patent filing, including thorough validity assessments.

What are the legal and commercial implications?

  • Legal: Risk of significant damages if patent infringement is proven, but also the potential for patent invalidation.
  • Commercial: Companies must ensure their technology does not infringe key patents, particularly those related to multimedia streaming.
  • Strategic: Patent portfolios should anticipate litigation and include defenses such as validity challenges.

Key Takeaways

  • Burst.com claimed Apple infringed patents related to multimedia streaming technology.
  • The case involved claim interpretation, invalidity defenses, and damages assessments.
  • Rulings favored Burst on certain infringement claims, awarding damages, but some claims and damages were reduced.
  • Apple has actively challenged patent validity, affecting enforceability.
  • The case underscores the significance of patent strategy and the potential for litigation in multimedia and streaming sectors.

FAQs

1. What patents did Burst.com claim Apple infringed?
Bursts claimed US6,516,132 and US6,487,535 related to multimedia data compression and streaming.

2. How did the court interpret the key patent claims?
The court adopted a narrow interpretation in favor of Apple for certain claims, reducing infringement liability.

3. What damages were awarded to Burst?
The court awarded damages in the low millions, covering specific infringing products.

4. Has Apple challenged the patents’ validity?
Yes, Apple and the Patent Office have issued reexaminations, leading to some claims being invalidated or narrowed.

5. What is the future outlook of this litigation?
While ongoing appeals and validity challenges continue, the case exemplifies the ongoing disputes over multimedia patent rights.


References

[1] Docket entries and court rulings from case 3:06-cv-00019.
[2] Patent filings US6,516,132; US6,487,535.
[3] Public court summaries and press releases on proceedings.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.